Connect with us

Business

EIA Sees WTI Crude Averaging $44 In 2021 – OilPrice.com

Published

 on



EIA Sees WTI Crude Averaging $44 In 2021 | OilPrice.com

Charles Kennedy

Charles Kennedy

Charles is a writer for Oilprice.com

More Info

Trending Discussions

    Premium Content

    Loop oil tanks

    WTI Crude oil prices are expected to average $44.24 per barrel next year, the EIA said in its latest Short-Term Energy Outlook (STEO), with the forecast price not much higher than the $42 spot price early on Wednesday.  

    This year, WTI Crude prices are expected to average $38.24 per barrel, according to the EIA, which revised down slightly its estimates for the U.S. benchmark and for the international Brent benchmark compared to its estimates in the October STEO.  

    In the November STEO this week, the EIA sees Brent Crude prices averaging $40.61 in 2020 and $46.59 next year. This compares to estimates of $41.19 for this year and $47.07 a barrel for 2021 in the October STEO. The October outlook also had higher price projections for WTI compared to the November forecasts. The October average estimate for 2020 was $38.76 a barrel, while the forecast for 2021 was $44.72.

    EIA sees the record high global cases of COVID-19 and the return of Libyan oil sooner than market participants had expected as the main headwinds to oil prices now. The administration expects global inventories to continue falling in the coming months, but “high global oil inventory levels and surplus crude oil production capacity will limit upward pressure on oil prices,” it said.

    Brent prices will likely stay near $40 a barrel through the end of 2020, the EIA said, and warned of downside risks.

    “Uncertainty about responses to increasing COVID-19 cases presents downside risk to EIA’s global oil demand forecast for the fourth quarter of 2020 and first half of 2021,” according to the EIA, which also cut its estimate for global oil consumption between Q4 and mid-2021 by 400,000 bpd compared to the estimate from October.

    “The pace of oil demand recovery will affect not only expectations of petroleum inventory withdrawals but also could affect planned oil supply increases” from the OPEC+ group, whose production “will generally be tailored to match the pace of global oil demand recovery,” the EIA said.

    By Charles Kennedy for Oilprice.com

    More Top Reads From Oilprice.com:

    Download The Free Oilprice App Today


    Back to homepage

    <!–

    Trending Discussions

      –>



      Related posts

      Let’s block ads! (Why?)



      Source link

      Continue Reading

      Business

      Former Fed Chair Janet Yellen reportedly Biden pick for Treasury Secretary – Yahoo Canada Finance

      Published

       on


      GlobeNewswire

      Global Regenerative Medicine Market 2020-2025: Opportunities with the Implementation of the 21st Century Cures Act

      Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) — The “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. The Global Regenerative Medicine Market is Projected to Reach USD 17.9 Billion by 2025 from USD 8.5 Billion in 2020, at a CAGR of 15.9% during the Forecast Period. Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products. However, the high cost of cell and gene therapies and ethical concerns related to the use of embryonic stem cells in research and development are expected to restrain the growth of this market during the forecast period.The cell therapies segment accounted for the highest growth rate in the regenerative medicine market, by product, during the forecast periodBased on products, the regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The cell therapies segment accounted for the highest growth rate in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.Oncology segment accounted for highest CAGRBased on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders. Europe: The fastest-growing region regenerative medicine marketThe global regenerative medicine market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. The North America region is projected to grow at the highest CAGR during the forecast period in 2019. The growth in the North American regenerative medicine market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases. Market Dynamics Drivers * Rising Prevalence of Chronic Diseases, Genetic Disorders, and Cancer * Rising Investments in Regenerative Medicine Research * Growing Pipeline of Regenerative Medicine ProductsRestraints * Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development * High Cost of Cell and Gene TherapiesOpportunities * Implementation of the 21st Century Cures Act * Rising Demand for Organ TransplantationsImpact of the COVID-19 Pandemic on the Regenerative Medicine MarketCompanies Mentioned * 3M Group * Allergan * Amgen, Inc. * Anterogen Co., Ltd. * APAC Biotech * Aspect Biosystems * Bluebird Bio * Corestem, Inc. * Integra Lifesciences Holdings Corporation * Kite Pharma * Medipost Co., Ltd. * Medtronic plc * Mimedx Group * Misonix * Novartis Ag * Organogenesis Inc. * Orthocell Ltd. * Shenzhen Sibiono Genetech Co., Ltd. * Smith & Nephew plc * Spark Therapeutics * Stryker Corporation * Takeda Pharmaceutical Company Limited * Tego Science, Inc. * Vericel Corporation * Zimmer BiometFor more information about this report visit https://www.researchandmarkets.com/r/6v7acfResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

      Let’s block ads! (Why?)



      Source link

      Continue Reading

      Business

      Peel Public Health reporting COVID-19 outbreaks at Brampton schools – Brampton Guardian

      Published

       on


      [unable to retrieve full-text content]

      1. Peel Public Health reporting COVID-19 outbreaks at Brampton schools  Brampton Guardian
      2. Toronto enters virus lockdown as US looks to vaccine rollout  RFI
      3. Coronavirus: Latest developments in the Greater Toronto Area on Nov. 23  Global News
      4. Record number of new coronavirus cases reported in Ontario as lockdowns begin in Toronto, Peel  CP24 Toronto’s Breaking News
      5. Ontario’s top public health official now plans to push back retirement amid second wave of pandemic  CP24 Toronto’s Breaking News
      6. View Full coverage on Google News



      Source link

      Continue Reading

      Business

      Toronto rolling out 'targeted' COVID-19 response for red-hot neighbourhoods – CP24 Toronto's Breaking News

      Published

       on


      Toronto is launching an enhanced COVID-19 response program targeting some of the city’s hardest hit neighborhoods.

      Mayor John Tory announced the program during the city’s COVID-19 update Monday as the Toronto came under a provincially mandated lockdown to try curb the spread of the disease.

      “We can’t stop the spread of COVID-19 in some parts of our city while it rages like wildfire in other parts of the city and we owe it to the most vulnerable to make sure that extra measures are provided, extra supports are provided in their fight against COVID-19,” Tory said. “We have to fight this virus everywhere, and we have to stop it everywhere.”

      Data collected by Toronto Public Health have shown that case numbers and positivity rates are higher in certain areas of the city while testing rates are lower, particularly in the northwest corner of the city and northeast Scarborough.

      Tory said the data show that the virus is having a disproportionate impact on people who are Indigenous, Black or racialized, precariously employed, live on low income, live in multi-generational housing, or who experience challenges taking time from work when ill.

      “We are ramping up our support plan to fix this, in partnership with 11 highly trusted community based partners,” Tory said. “The city is immediately launching an urgent set of initiatives in targeted neighborhoods to increase supports and testing for residents in COVID-19 hotspots.

      “This is an all hands on deck effort. Every part of the city government that we can mobilize is involved.”

      Those measures will include a broader sharing of public health information, improving access to COVID-19 testing, as well as “critical supports” to those who test positive, and to their families in order to address testing hesitancy.  

      Tory said the city is working on expanding the number of provincial testing sites, using buses for more mobile testing, and providing more transportation to testing sites with expanded hours.

      The city is also continuing to lobby higher levels of government to continue or implement further supports to help those who are most vulnerable.

      In particular, Tory said the city is renewing a request for the province to continue a ban on residential evictions during the pandemic.

      Another major problem affecting some parts of the city is hesitation to get tested for fear that a positive test will mean loss pf income.

      “Right now, people in the City of Toronto are waking up with COVID-19 symptoms, going to work, and giving the virus to their coworkers. Why, because they fear losing their jobs and or their paycheck, and they feel compelled to continue working without getting tested so they can put food on the table,” Tory said.

      Tory said current federal and provincial supports for workers who have to take time off to isolate are either inadequate or net well understood. He said he has raised the matter with federal and provincial ministers but in the meantime is calling on employers to “do the right thing” by supporting workers who have to take time off to isolate because they have tested positive or have symptoms.

      Following Tory, Toronto’s Medical Officer of Health Dr. Eileen de Villa reiterated that many frontline workers are relying on those who can stay home as much as possible to do so.

      “We owe it to them, those of us who can choose to keep apart more than others. We owe it to them to choose wisely and in ways that limit the risk for those who don’t have the choice to keep apart, and who may be at an even greater risk of getting sick because of it,” de Villa said. “This is truer for some communities in Toronto than others.”

      De Villa said she remains “very worried” about where the city is going in terms of its progress in fighting the pandemic and urged people to reduce unnecessary trips and interactions in order to do their part.

      “I urge you to act with the care and caution that we all showed last spring,” she said. “As I’ve said many times, with each choice we are able to make, we can lessen the likelihood of worse infection rates and soften the blow of what is yet to come.”

      She said the possibility of allowing gatherings at Christmas and other events into next year depend on how well the city does in containing the spread of the virus during the current lockdown. 

      Let’s block ads! (Why?)



      Source link

      Continue Reading

      Trending